Loading organizations...
Loading organizations...
Biotechnology company developing immunotherapy treatments for diseases.
Argos Therapeutics has raised $86.5M across 4 funding rounds.
Argos Therapeutics has raised $86.5M in total across 4 funding rounds.
Argos Therapeutics has raised $86.5M in total across 4 funding rounds.
Argos Therapeutics's investors include Lummy, Aurora Funds, Forbion, Green Cross Holdings, Intersouth Partners, Lumira Ventures, Morningside, Pharmstandard International, TVM Capital, Alexandr Shuster.
Argos Therapeutics has raised $86.5M across 4 funding rounds. Most recently, it raised $1.5M Other Equity in January 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 10, 2018 | $1.5M Other Equity | Lummy | |
| Nov 20, 2013 | $17.5M Series E Extension | Aurora Funds, Forbion, Green Cross Holdings, Intersouth Partners, Lumira Ventures, Morningside, Pharmstandard International, TVM Capital | |
| Aug 28, 2013 | $42.5M Series E | Alexandr Shuster | Aurora Funds, Forbion, Green Cross Holdings, Intersouth Partners, Lumira Ventures, Morningside, TVM Capital |
| Apr 24, 2012 | $25.0M Series D | Forbion | Aurora Funds, Intersouth Partners, Lumira Ventures, Morningside, TVM Capital |